This issue is organized into four sections: (I) Evolution In Cancer Treatment: Adding Genomics to Histology; (II) Biologics in Various GI Malignancies; (III) Challenges in Biologics; (IV) Ongoing Perspectives and Clinical Trials. It is dedicated to providing readers with an updated and concise overview of novel biologics that are being developed or tested in various GI cancer types. Efforts toward the molecular classification for each GI cancer type will be discussed, and expert insight into the challenges of precision oncology including treatment resistance, side effects and cost-effectiveness will be presented.
Read More>>
Disclosure:
The series “Novel Biologics in Era of Precision Medicine” was commissioned by the editorial office, Journal of Gastrointestinal Oncology without any sponsorship or funding. Andrea Wang-Gillam and Kian-Huat Lim served as the unpaid Guest Editors for the series.
